Pelthos Therapeutics Statistics
Total Valuation
PTHS has a market cap or net worth of $76.84 million. The enterprise value is $93.16 million.
Important Dates
The next estimated earnings date is Saturday, May 9, 2026, before market open.
| Earnings Date | May 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTHS has 3.36 million shares outstanding. The number of shares has increased by 237.34% in one year.
| Current Share Class | 3.36M |
| Shares Outstanding | 3.36M |
| Shares Change (YoY) | +237.34% |
| Shares Change (QoQ) | +3.04% |
| Owned by Insiders (%) | 5.71% |
| Owned by Institutions (%) | 25.54% |
| Float | 1.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.54 |
| Forward PS | 1.23 |
| PB Ratio | 1.89 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.90.
| Current Ratio | 2.05 |
| Quick Ratio | 1.03 |
| Debt / Equity | 0.90 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.43 |
Financial Efficiency
Return on equity (ROE) is -239.55% and return on invested capital (ROIC) is -53.65%.
| Return on Equity (ROE) | -239.55% |
| Return on Assets (ROA) | -29.80% |
| Return on Invested Capital (ROIC) | -53.65% |
| Return on Capital Employed (ROCE) | -30.08% |
| Weighted Average Cost of Capital (WACC) | 20.14% |
| Revenue Per Employee | $182,554 |
| Profits Per Employee | -$470,859 |
| Employee Count | 92 |
| Asset Turnover | 0.25 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -7.39M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +74.81% in the last 52 weeks. The beta is 3.99, so PTHS's price volatility has been higher than the market average.
| Beta (5Y) | 3.99 |
| 52-Week Price Change | +74.81% |
| 50-Day Moving Average | 23.01 |
| 200-Day Moving Average | 25.04 |
| Relative Strength Index (RSI) | 50.87 |
| Average Volume (20 Days) | 8,326 |
Short Selling Information
The latest short interest is 82,536, so 2.46% of the outstanding shares have been sold short.
| Short Interest | 82,536 |
| Short Previous Month | 80,181 |
| Short % of Shares Out | 2.46% |
| Short % of Float | 5.86% |
| Short Ratio (days to cover) | 14.66 |
Income Statement
In the last 12 months, PTHS had revenue of $16.80 million and -$43.32 million in losses. Loss per share was -$23.04.
| Revenue | 16.80M |
| Gross Profit | 11.58M |
| Operating Income | -31.41M |
| Pretax Income | -50.71M |
| Net Income | -43.32M |
| EBITDA | -29.12M |
| EBIT | -31.41M |
| Loss Per Share | -$23.04 |
Full Income StatementBalance Sheet
The company has $17.97 million in cash and $34.83 million in debt, with a net cash position of -$16.86 million or -$5.02 per share.
| Cash & Cash Equivalents | 17.97M |
| Total Debt | 34.83M |
| Net Cash | -16.86M |
| Net Cash Per Share | -$5.02 |
| Equity (Book Value) | 38.88M |
| Book Value Per Share | 12.02 |
| Working Capital | 27.42M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$22.59 million and capital expenditures -$99,000, giving a free cash flow of -$22.69 million.
| Operating Cash Flow | -22.59M |
| Capital Expenditures | -99,000 |
| Depreciation & Amortization | 2.29M |
| Net Borrowing | 17.75M |
| Free Cash Flow | -22.69M |
| FCF Per Share | -$6.76 |
Full Cash Flow StatementMargins
Gross margin is 68.94%, with operating and profit margins of -187.01% and -257.93%.
| Gross Margin | 68.94% |
| Operating Margin | -187.01% |
| Pretax Margin | -301.91% |
| Profit Margin | -257.93% |
| EBITDA Margin | -173.40% |
| EBIT Margin | -187.01% |
| FCF Margin | n/a |
Dividends & Yields
PTHS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -237.34% |
| Shareholder Yield | -237.34% |
| Earnings Yield | -56.77% |
| FCF Yield | -29.73% |
Analyst Forecast
The average price target for PTHS is $54.17, which is 136.55% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $54.17 |
| Price Target Difference | 136.55% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 71.21% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 2, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
PTHS has an Altman Z-Score of -0.85 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.85 |
| Piotroski F-Score | 2 |
